The company
Corcept Therapeutics Incorporated
CORT · Nasdaq
CORT stood above a rising 150-day average in 25 of the last 52 weekly readings, including each of the last 17 weeks. It is 32.5% above that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 17 in a row
- Industry in uptrend
- 31% -7 in 4 wk
- Insider buys, 12 months
- $6.6M
- Insider sales, 12 months
- $183.1M
- Officials’ trades on record
- 10
- Institutions holding
- 391 (+68)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 25 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
10 disclosed lines: House 3, Senate 0, executive 7; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 30 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 4 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 26 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $50k–$100k | 26 Jan 2026filed 14 May 2026 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $15k–$50k | 15 Dec 2017filed 21 Dec 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 20 Nov 2017filed 6 Dec 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 11 Oct 2017filed 18 Oct 2017 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| James N. WilsonDirector | sold | 6,654at $114.48 | 15 Oct 2026filed 16 Oct 2026 |
| James N. WilsonDirector | sold | 3,046at $115.39 | 15 Oct 2026filed 16 Oct 2026 |
| James N. WilsonDirector | sold | 300at $116.30 | 15 Oct 2026filed 16 Oct 2026 |
| Sean MaduckOfficer | sold | 15,843at $116.12 | 2 Oct 2026filed 5 Oct 2026 |
| Sean MaduckOfficer | sold | 8,744at $116.55 | 2 Oct 2026filed 5 Oct 2026 |
| Joseph Douglas LyonOfficer | sold | 4,446at $115.70 | 2 Oct 2026filed 5 Oct 2026 |
| Joseph Douglas LyonOfficer | sold | 4,744at $116.54 | 2 Oct 2026filed 5 Oct 2026 |
| Roberto Wandenkolk VieiraPresident, Oncology | sold | 1,100at $114.52 | 2 Oct 2026filed 5 Oct 2026 |
| Roberto Wandenkolk VieiraPresident, Oncology | sold | 2,086at $115.73 | 2 Oct 2026filed 5 Oct 2026 |
| Roberto Wandenkolk VieiraPresident, Oncology | sold | 5,147at $116.59 | 2 Oct 2026filed 5 Oct 2026 |
| Sean MaduckOfficer | sold | 413at $115.54 | 1 Oct 2026filed 5 Oct 2026 |
| Joseph Douglas LyonOfficer | sold | 810at $115.40 | 1 Oct 2026filed 5 Oct 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 12,432,023$1.1B | +280,747+2.3% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 5,261,628$457.5M | -421,155−7.4% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 5,044,638$438.6M | +224,070+4.6% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 4,172,482$362.8M | +95,286+2.3% |
| Parallel Advisors, LLCreduced · filed 5 Aug 2026 | 3,962,177$344.5M | -15,227−0.4% |
| FMR LLCadded · filed 13 Aug 2026 | 3,337,618$290.2M | +147,426+4.6% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,279,381$285.2M | +78,435+2.5% |
| AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 2,582,561$224.6M | +2,176,356+535.8% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 2,532,198$220.2M | -181,321−6.7% |
| FIRST TRUST ADVISORS LPreduced · filed 11 Aug 2026 | 1,829,545$159.1M | -343,831−15.8% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.